Related Experiment Video
Updated: Jun 5, 2025

10:27
Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
7.2K
Vebreltinib: a promising milestone in targeted therapy for METex14-mutant NSCLC
LinRui Ma1, WeiKang Meng2, WenJuan Jiang3
1Department of Medical Oncology, Lung Cancer and Gastrointestinal Unit, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, 410013, China.
Investigational New Drugs
|December 16, 2024
Abstract
No abstract available in PubMed .

